UIM6:XETRA:XETRA-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 496.59

Change

+1.20 (+0.24)%

Market Cap

USD 0.47B

Volume

85.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing UIM6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.54% 85% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.54% 84% B 82% B
Trailing 12 Months  
Capital Gain 27.67% 79% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.67% 79% B- 77% C+
Trailing 5 Years  
Capital Gain 96.47% 94% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 96.47% 94% A 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.71% N/A N/A 83% B
Dividend Return 14.88% N/A N/A 82% B
Total Return 0.17% N/A N/A 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 14.87% N/A N/A 49% F
Risk Adjusted Return 100.07% N/A N/A 96% N/A
Market Capitalization 0.47B 64% D 56% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike